Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Marijn Verhoef joins the Panmure House Dialogues on AMR

Marijn Verhoef, Director of Private Sector Engagement at the Access to Medicine Foundation, will attend the first Panmure House Dialogues focused on the economic impact of antimicrobial resistance (AMR), where he will share insights from the Foundation’s AMR Programme.

Date

06 November 2025

Location

Edinburgh

The Panmure House Dialogues will bring together leaders in policymaking, the pharmaceutical industry, biotechnology, finance and academia to discuss the economic impact of antimicrobial resistance (AMR), and strategies for mitigating drug resistance that balance public health priorities with investment feasability. 

In the first session, panellists will discuss how to attract more investors to fund the protection of antimicrobial products’ effectiveness and the need for cross-sector coordination in creating strategies around this goal. 

The dialogue chairs will include Adam Dixon, chair of Adam Smith at Adam Smith’s Panmure House, part of Edinburgh Business School, and Lucy Naga, postdoctoral researcher in Economics at Heriot-Watt University, who manages the Panmure House Dialogues. 

Marijn Verhoef, Director of Private Sector Engagement at the Access to Medicine Foundation, will attend the meeting. He plans to highlight the importance of allocating resources to the research and development of new antimicrobial products, drawing insights from the Access to Medicine Foundation’s AMR Research Programme.  

Insights from the dialogues will be used to create a series of white papers for guiding policy and investment communities’ strategies. 

About the Panmure House Dialogues 

The Panmure House Dialogues are a new series of events set to take place at the Adam Smith House in Edenborough, providing a platform for experts to discuss the impact of AMR to the global economy, as well as strategies for mitigating against it through investment. 

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch
News

New methodology paves the way for the Foundation's 2026 AMR Benchmark

28 January 2025
News

More superbugs, fewer drugs. How can pharma companies ensure the handful of promising antimicrobials make it to the frontlines of drug resistance?

23 May 2024
News

What steps are companies taking to help curb AMR by manufacturing responsibly?

22 August 2023

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved